Published in J Reward Defic Syndr on August 25, 2015
Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality. Clin Med Rev Case Rep (2015) 0.75
Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). J Reward Defic Syndr Addict Sci (2017) 0.75
Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission. J Syst Integr Neurosci (2017) 0.75
"Pro-dopamine regulation (KB220Z™)" as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America. J Syst Integr Neurosci (2016) 0.75
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 14.17
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 11.96
A psychobiological model of temperament and character. Arch Gen Psychiatry (1993) 10.95
Dynamic spread of happiness in a large social network: longitudinal analysis over 20 years in the Framingham Heart Study. BMJ (2008) 10.80
The neurobiology of addiction: implications for voluntary control of behavior. Am J Bioeth (2007) 9.36
Model of genetic variation in human social networks. Proc Natl Acad Sci U S A (2009) 8.73
Drinking to regulate positive and negative emotions: a motivational model of alcohol use. J Pers Soc Psychol (1995) 8.48
Brain dopamine and obesity. Lancet (2001) 8.00
The influence of social hierarchy on primate health. Science (2005) 6.88
Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci (2010) 5.98
Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science (2010) 5.48
Stages in adolescent involvement in drug use. Science (1975) 5.25
Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA (1990) 5.04
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 4.88
Beyond the hedonic treadmill: revising the adaptation theory of well-being. Am Psychol (2006) 4.62
Brain dopamine and reward. Annu Rev Psychol (1989) 4.41
Genetic influences on measures of the environment: a systematic review. Psychol Med (2006) 3.93
The addicted human brain: insights from imaging studies. J Clin Invest (2003) 3.91
Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol (1996) 3.65
Would you be happier if you were richer? A focusing illusion. Science (2006) 3.62
Cloning and expression of a rat D2 dopamine receptor cDNA. Nature (1989) 3.59
Neural correlates of attentional expertise in long-term meditation practitioners. Proc Natl Acad Sci U S A (2007) 3.56
Kin recognition in an annual plant. Biol Lett (2007) 3.32
The changing nature of psychiatry. Aust N Z J Psychiatry (1991) 3.31
Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 3.21
The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev (2005) 3.17
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem (1995) 3.08
Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol (1998) 3.07
Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci (2008) 2.97
Know your place: neural processing of social hierarchy in humans. Neuron (2008) 2.92
Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs (2000) 2.82
Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A (1983) 2.76
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A (2007) 2.62
Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res (2000) 2.58
Shattuck Lecture. A molecular basis for nicotine as a gateway drug. N Engl J Med (2014) 2.57
Spiritual issues in the care of dying patients: ". . . it's okay between me and god". JAMA (2006) 2.43
Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci (1983) 2.31
Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry (1991) 2.30
Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci (2008) 2.27
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet (1989) 2.25
Alcohol: effects on neurobehavioral functions and the brain. Neuropsychol Rev (2007) 2.20
Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology (2008) 2.16
Decreased volume of the brain reward system in alcoholism. Biol Psychiatry (2008) 2.15
Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia (2004) 2.07
The role of brain emotional systems in addictions: a neuro-evolutionary perspective and new 'self-report' animal model. Addiction (2002) 2.03
Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci U S A (2007) 2.02
Tourette syndrome is associated with recurrent exonic copy number variants. Neurology (2010) 1.99
The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med (1996) 1.98
High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry (2006) 1.97
Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet (2008) 1.97
Molecular neurobiology of addiction. Am J Addict (2001) 1.97
Hedonic hot spots in the brain. Neuroscientist (2006) 1.96
Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs (2009) 1.96
Neural underpinnings of within-person variability in cognitive functioning. Psychol Aging (2009) 1.91
Influence of phasic and tonic dopamine release on receptor activation. J Neurosci (2010) 1.86
Adaptation - not by sweeps alone. Nat Rev Genet (2010) 1.85
A randomized controlled trial of intensive referral to 12-step self-help groups: one-year outcomes. Drug Alcohol Depend (2007) 1.83
The process addictions and the new ASAM definition of addiction. J Psychoactive Drugs (2012) 1.82
The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics (1996) 1.81
Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology (2005) 1.79
The serotonin system and spiritual experiences. Am J Psychiatry (2003) 1.79
Correlated genotypes in friendship networks. Proc Natl Acad Sci U S A (2011) 1.76
Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci (2007) 1.66
Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem (2001) 1.66
New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev (1985) 1.61
Transient changes in mesolimbic dopamine and their association with 'reward'. J Neurochem (2002) 1.59
Molecular mechanisms in the receptor action of benzodiazepines. Annu Rev Pharmacol Toxicol (1979) 1.59
Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders. Med Hypotheses (2005) 1.58
Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev (2010) 1.57
Substance abuse vulnerability and D2 receptor genes. Trends Neurosci (1993) 1.55
Increased dopamine tone during meditation-induced change of consciousness. Brain Res Cogn Brain Res (2002) 1.55
Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry (2011) 1.53
Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity (Silver Spring) (2011) 1.52
Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet (2005) 1.52
The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol (2005) 1.45
Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology (2012) 1.45
The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J Pharmacol Exp Ther (2009) 1.45
Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology (2009) 1.45
Gender differences in friends' influences on adolescent drinking: a genetic epidemiological study. Alcohol Clin Exp Res (2007) 1.44
Genes, cognition and brain through a COMT lens. Neuroscience (2009) 1.43
Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics (1996) 1.43
Happiness and health: environmental and genetic contributions to the relationship between subjective well-being, perceived health, and somatic illness. J Pers Soc Psychol (2003) 1.41
Neurobehavioral evidence for changes in dopamine system activity during adolescence. Neurosci Biobehav Rev (2009) 1.41
Addiction and brain reward and antireward pathways. Adv Psychosom Med (2011) 1.38
Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics (1991) 1.38
D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse (2008) 1.38
Frontal white matter and cingulum diffusion tensor imaging deficits in alcoholism. Alcohol Clin Exp Res (2008) 1.38
Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum Genet (2006) 1.37
The molecular genetics of executive function: role of monoamine system genes. Biol Psychiatry (2011) 1.36
Genetic and environmental influences in adolescent peer socialization: evidence from two genetically sensitive designs. Child Dev (2004) 1.35
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model (2008) 1.35
Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics (1995) 1.35
In 12-step groups, helping helps the helper. Addiction (2004) 1.33
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) (1994) 1.29
Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics. Addict Biol (2011) 1.27
Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Neuroscience (2009) 1.27
Dopamine functions in appetitive and defensive behaviours. Prog Neurobiol (1992) 1.26
The determination of defense style by questionnaire. Arch Gen Psychiatry (1989) 1.26
Self-help for substance-use disorders: history, effectiveness, knowledge gaps, and research opportunities. Clin Psychol Rev (2003) 1.25
NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity. J Reward Defic Syndr (2015) 0.77
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward. J Reward Defic Syndr (2015) 0.76
Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. J Reward Defic Syndr (2015) 0.75